SAE Media Group reports: The brochure is available to download for the 4th Annual AI in Drug Discovery Conference in London.

LONDON, UK, December 6, 2022 /EINPresswire.com/ -- SAE Media Group is proud to present the return of the AI in Drug Discovery Conference for its 4th year in London, on 13 – 14 March 2023.

With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through the use of machine and deep learning. The current challenges within the drug discovery industry include the significant time consumption and expenses involved. This conference will discuss the solutions to these problems with presentations and updates from leading industry experts.

AI in drug discovery is leading the way into a shorter, cheaper and more successful R&D era where compound generation is automated, drug synthesis is predictable and undruggable diseases are finally being targeted.

Visit the website at: http://www.ai-indrugdiscovery.com/PR1ein to find out more about the conference

AI in Drug Discovery Conference will be proudly chaired by Darren Green, Head of Cheminformatics and Data Science from GSK. Darren Green will be speaking on day one of the conference on ‘Applying AI/ML in the Drug Discovery Processes from Hypothesis Testing to Preclinical Screening’, focusing on:
• Overcoming the challenges currently facing pharmaceutical R&D programmes with data science and AI
• Opportunities for data analysis and predictive modelling in drug discovery
• Profitable applications to translate AI/ML from the lab to the clinic
• Open data sharing? - The importance of long-term planning

Delegates attending will have the opportunity to gain valuable insights on how to implement AI and Machine Learning techniques throughout the discovery pipeline from antigens and genomics to proteins and peptides and utilise breakthroughs in robotics, automation and quantum chemical methods.

To download the brochure and view the full agenda, please visit:
http://www.ai-indrugdiscovery.com/PR1ein

For sponsorship enquiries, please contact Andrew Gibbons on +44 (0) 20 7827 6156 or andrew.gibbons@saemediagroup.com

For delegate enquiries, please contact Sarah Nobrega on +44 (0) 20 7827 6021 or
sarah.nobrega@saemediagroup.com

4th Annual AI in Drug Discovery Conference
13 – 14 March 2023
London, UK
http://www.ai-indrugdiscovery.com/PR1ein
#AIDrugDis

----------- END ----------

About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

Hannah Blake
SAE Media Group
+442078276106 ext.
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.